Capital Flow Monitor · Sponsors · CIK 1708135
Avery Therapeutics, Inc.
2500 N. TUCSON BLVD. STE. 140, TUCSON, AZ, 85716 · 520-977-4980
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$15.4M
Sold
$8.5M
% sold
55.0%
Investors
23
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-09-21 | D ·current | 506(b) | $15.4M | $8.5M | 55.0% | 23 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Jordan Lancaster — Executive Officer / Director, Tucson, AZ
- Lawrence Mehren — Director, Tucson, AZ
- Emile Nuwaysir — Director, Tucson, AZ
- Steven Goldman — Executive Officer, Tucson, AZ
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.